NBTXR3 Crystalline Nanoparticles and Stereotactic Body Radiation Therapy in the Treatment of Liver Cancers

NCT02721056 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped The RP2D for intratumoral injection was determined. With the changing practice of medicine for HCC, it was decided to design an independent Phase II clinical study.

Conditions

Interventions

Sponsor

Nanobiotix